Impaired differentiation and cytotoxicity of natural killer cells in systemic lupus erythematosus. - Wikidata - awgldk - TriplyDB

Impaired differentiation and cytotoxicity of natural killer cells in systemic lupus erythematosus.

Impaired differentiation and cytotoxicity of natural killer cells in systemic lupus erythematosus.

http://www.wikidata.org/entity/Q33384708

about

Functional Significance of CD57 Expression on Human NK Cells and Relevance to Disease Gene expression profiles in a rabbit model of systemic lupus erythematosus autoantibody production NKG2D ligand overexpression in lupus nephritis correlates with increased NK cell activity and differentiation in kidneys but not in the periphery.Genomic pathology of SLE-associated copy-number variation at the FCGR2C/FCGR3B/FCGR2B locus.Pulmonary manifestations in Behçet disease: impaired natural killer cells activity Involvement of CD226+ NK cells in immunopathogenesis of systemic lupus erythematosus Expansion of an atypical NK cell subset in mouse models of systemic lupus erythematosus.Perforin: an important player in immune response.Bone destruction by receptor activator of nuclear factor κB ligand-expressing T cells in chronic gouty arthritis.Infection and Lupus: Which Causes Which?Dysfunction of natural killer T cells in patients with active Mycobacterium tuberculosis infection RNA-seq Analysis Reveals Unique Transcriptome Signatures in Systemic Lupus Erythematosus Patients with Distinct Autoantibody Specificities Cardif (MAVS) Regulates the Maturation of NK Cells Ankylosing spondylitis: from cells to genes Natural killer cells and their receptors in multiple sclerosis.NK cell autoreactivity and autoimmune diseases.Clinical relevance of circulating mucosal-associated invariant T cell levels and their anti-cancer activity in patients with mucosal-associated cancer.Natural killer cells in human autoimmune disorders Natural killer cells in human autoimmune diseases.The dynamic evolution of rheumatology in Korea.Association study of MICA gene polymorphisms with rheumatoid arthritis susceptibility in south Tunisian population.Could Lymphocyte Profiling be Useful to Diagnose Systemic Autoimmune Diseases?Role of the MICA polymorphism in systemic lupus erythematosus.Increased level and interferon-γ production of circulating natural killer cells in patients with scrub typhus.Circulating NK cells and their subsets in Behçet's disease.Evaluation of NK cell function by flowcytometric measurement and impedance based assay using real-time cell electronic sensing system.Natural killer cell activity and frequency of killer cell immunoglobulin-like receptors in children with different forms of juvenile idiopathic arthritis.NK cells dysfunction in systemic lupus erythematosus: relation to disease activity.Cell surface expression of activating receptors and co-receptors on peripheral blood NK cells in systemic autoimmune diseases.Role of cytolytic impairment of natural killer and natural killer T-cell populations in rheumatoid arthritis.Diversification of human NK cells: Lessons from deep profiling.Differential microRNA profile and post-transcriptional regulation exist in systemic lupus erythematosus patients with distinct autoantibody specificities.Analysis of the regulatory function of natural killer cells from patients with systemic lupus erythematosus.Unraveling the expression of microRNA-27a* & NKG2D in peripheral blood mononuclear cells and natural killer cells of pediatric systemic lupus erythematosus patients.Association of killer cell immunoglobulin-like receptor (KIR) genes and their HLA ligands with susceptibility to Behçet's‎ disease.Altered expression of signalling lymphocyte activation molecule receptors in T-cells from lupus nephritis patients-a potential biomarker of disease activity.Downregulation of CD3ζ in NK Cells from Systemic Lupus Erythematosus Patients Confers a Proinflammatory Phenotype.Natural Killer Cell Subsets and Their Functional Activity in Behçet's Disease.Genome-wide association study identifies new susceptibility loci for cutaneous lupus erythematosus.Functional anti-CD94/NKG2A and anti-CD94/NKG2C autoantibodies in patients with systemic lupus erythematosus.

P2860

Q27022458-A102C3D8-B97D-4119-9752-49F64912C6AC Q30496834-A7AF87D4-102A-417C-BCB3-4949D0F99284 Q33816779-A39AA65B-DD59-4349-A37A-1334263C6D6D Q34319137-33E9F3BB-C55E-444F-8A99-BB1A91F05957 Q34650090-84D8D359-3306-4B90-9F84-E3BB6749519B Q34989378-06A80334-BE6B-477F-A537-D0DDF6C41B29 Q35070929-B2F57D82-19FA-44BA-ACCA-CB590150A72C Q35631712-09A6B445-8F19-4790-8ABD-FE4DB8C050A3 Q35840782-C84F2966-0C89-4C83-A473-0672F34A6E19 Q35948285-C92EA16F-9101-4F31-BECD-8758AD4AB89A Q36018172-1AEE1C4B-27A0-413A-83B8-C4BCEFDD927D Q36190001-2781D17E-93AC-49B2-9E83-EEF81023BC12 Q36451854-1F1BAFB1-2A8F-4105-B75D-C1822566F769 Q37077734-B252597F-A1F3-4554-8530-EC18D1449D9F Q37124504-80C94DD6-BE73-4A97-89AB-F028F3BA1084 Q37552129-A582CA35-1F19-460B-9372-0F1AA098D3FF Q37689104-C7911A0A-6BEC-470C-BD3F-23D32ED8256E Q37690952-A78F3066-28AF-46E4-BFE8-46218986CB8B Q37805560-728879E7-FACF-4B23-BB46-835D60A0CFFC Q38671481-A15400CD-FD59-4885-8819-A187F227F661 Q38859292-8EA4A102-C7EF-4C5F-8563-2ABD6D565EE1 Q39285168-A7F98551-E907-453F-933E-CE292555DB04 Q39518838-5630E9C3-22F5-4FC8-A8D9-8465F1D08441 Q40117010-70B7AB4B-2B13-422B-88A8-00FEE5CFFC45 Q42097602-B2B145AD-05E0-45EF-846F-2C2B839D52FE Q43537337-3D9FB70A-F951-4CCB-8606-A3603D3E4DEC Q43825311-4A7C5431-20B2-40B8-AFA8-1A16813AE4A8 Q45911459-697E9C39-9636-4F39-BAD6-81F2E38423C0 Q46093248-10D45134-8FC6-4910-B5B1-A68AE67736BC Q46897841-7B0E1FFC-D15E-42AC-8EEA-EA689CBE2FAC Q47551334-C95E23E1-32A9-4F70-A176-1BDE2F2A2045 Q47603082-81985CF8-5032-45E1-B546-F306F365E3CC Q47883271-07C6D247-FBF2-46C2-96E0-4FFACD432B84 Q48122826-93EBB4BC-D7EE-4690-8AF9-28251B3FFC0E Q50237514-1086716E-DBD0-447F-A315-0BB80D16A679 Q51067608-5B9746F4-46AC-446C-9C12-EA2DA174DA0F Q52722794-26DE105D-433F-4B07-B197-DD84301122A1 Q52777818-2DECBB4D-8377-45BC-89FA-96305D8542D1 Q52954693-6283D1F7-D0A5-406F-A7A8-C6F7D7625CA8 Q53079635-37C3A038-89C3-440F-8214-218958FBE2CB

P2860

Impaired differentiation and cytotoxicity of natural killer cells in systemic lupus erythematosus.

http://www.wikidata.org/entity/Q33384708

description

2009 nî lūn-bûn

@nan

2009 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Impaired differentiation and c ...... systemic lupus erythematosus.

@ast

Impaired differentiation and c ...... systemic lupus erythematosus.

@en

type

label

Impaired differentiation and c ...... systemic lupus erythematosus.

@ast

Impaired differentiation and c ...... systemic lupus erythematosus.

@en

prefLabel

Impaired differentiation and c ...... systemic lupus erythematosus.

@ast

Impaired differentiation and c ...... systemic lupus erythematosus.

@en

P1433

Q33384708-6502B4F4-6679-4E9A-B9C4-D94E30A1D64A

P1476

Q33384708-41EABAE8-C5A7-4304-8F4A-9547C60015E4

P2093

Q33384708-091802BB-1FA5-4AE4-9A3D-5731413FE31D

Q33384708-32B954DA-8D51-4F29-8C5D-0E3FF5A211CE

Q33384708-573860B1-F048-4FA2-983C-5C6C3173D238

Q33384708-6A18C758-0B89-4C71-9F69-1A55CB8541F2

Q33384708-83996CEE-061E-4E86-8AB6-12B70618838F

Q33384708-98DB7900-781E-4DA0-8CDE-FBD5CFD69B4B

Q33384708-9F8D0758-994F-4FD4-A9FF-729A0540EADF

Q33384708-AEE0E681-9A8B-4F62-AB2D-1ED981ABE35D

Q33384708-B3AFF105-D899-48C9-BBA1-393BCB841744

Q33384708-DC000D94-9396-4281-8E5C-3852E686C924

P2860

Q33384708-3E12288F-6139-44E4-A646-D2A485E25665

Q33384708-65883342-E725-4BBC-8DF4-F83413DB64DD

Q33384708-794C2EF1-93AC-4B74-87C9-8A964F141271

P304

Q33384708-541D056F-81B1-44CD-879A-383AB4FA7F0E

P31

Q33384708-7255D355-D0B5-4394-82DC-F51AF5EC1851

P356

Q33384708-8C6C22A3-B5CF-4F23-905D-2914DB362D13

P433

Q33384708-1A660409-BA70-40D0-84ED-6675129CB83A

P478

Q33384708-96CF5BAC-DE20-4D17-B65B-457F2F3223F9

P50

Q33384708-026125E2-B76A-443A-A02E-48E99822C39E

Q33384708-3AD30D05-906B-438D-AC2E-102647D5EFB7

P577

Q33384708-F63DBB8E-9687-45DC-960D-429A9E9E7F82

P5875

Q33384708-ED3C5435-7D99-45E8-A042-6388EB8A396F

P698

Q33384708-2C094EF6-B417-4AE5-A3FF-EBC41DFB4BF3

P921

Q33384708-97EE32D8-A12C-43C3-96E6-E11B0F8C6AA5

P356

P1433

Arthritis & Rheumatology

P1476

Impaired differentiation and c ...... systemic lupus erythematosus.

@en

P2093

Dae-Hyun Yoo

http://www.w3.org/2001/XMLSchema#string

Eun-Hee Lee

http://www.w3.org/2001/XMLSchema#string

Eun-Mi Kim

http://www.w3.org/2001/XMLSchema#string

Hwa-Youn Lee

http://www.w3.org/2001/XMLSchema#string

Hyung-Sik Kang

http://www.w3.org/2001/XMLSchema#string

Jeong-Jin Park

http://www.w3.org/2001/XMLSchema#string

Seung-Jung Kee

http://www.w3.org/2001/XMLSchema#string

Shin-Seok Lee

http://www.w3.org/2001/XMLSchema#string

Yong-Wook Park

http://www.w3.org/2001/XMLSchema#string

Young-Nan Cho

http://www.w3.org/2001/XMLSchema#string

P2860

Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria.

Lymphocyte subsets in a large cohort of patients with systemic lupus erythematosus.

Natural Killer (NK) cell deficiency associated with an epitope-deficient Fc receptor type IIIA (CD16-II)

P304

1753-1763

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ART.24556

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

60

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26250843

http://www.w3.org/2001/XMLSchema#string

P698

19479851

http://www.w3.org/2001/XMLSchema#string

P921